Januvia Side Effects
How can Januvia Side Effects affect You? | PatientsVille.com
View and Submit Januvia Side Effects
Your Januvia Side Effect submission can play a very important role. Reporting your experience could help identify an unknown risk and inform other patients and health care professionals.
Record and Track Your Side Effects
It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.
Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Alternative JANUVIA Names:SITAGLIPT
Active Ingredient: SITAGLIPT
Side Effects reported to FDA: 7472. View Januvia Adverse Reports
Januvia safety alerts: 2009
Reported deaths: 301
Reported hospitalizations: 2335
Sitagliptin (marketed as Januvia and Janumet) - acute pancreatitis
Audience: Diabetes healthcare professionals, patients
[Posted 09/25/2009] FDA notified healthcare professionals and patients of revisions to the prescribing information for Januvia (sitagliptin) and Janumet (sitagliptin/metformin) to include information on reported cases of acute pancreatitis in patients using these products. Eighty-eight post-marketing cases of acute pancreatitis, including two cases of hemorrhagic or necrotizing pancreatitis in patients using sitagliptin, were reported to the Agency between October 2006 and February 2009. It is recommended that healthcare professionals monitor patients carefully for the development of pancreatitis after initiation or dose increases of sitagliptin or sitagliptin/metformin. Sitagliptin has not been studied in patients with a history of pancreatitis. Therefore, it is not known whether these patients are at an increased risk for developing pancreatitis and the medication should be used with caution and with appropriate monitoring in patients with a history of pancreatitis. Considerations for healthcare professionals, information for patients, and a Data Summary are provided.
[09/25/2009 - Information for Healthcare Professionals - FDA]
Januvia Adverse Reactions
Blood Glucose Increased ( 614 Reports)|Hypoglycaemia ( 398 Reports)|Headache ( 384 Reports)|Pancreatitis ( 341 Reports)|Nausea ( 321 Reports)|Diarrhoea ( 278 Reports)|Dizziness ( 267 Reports)|Rash ( 231 Reports)|Dyspnoea ( 192 Reports)|Rhinorrhoea ( 187 Reports)|Oedema Peripheral ( 178 Reports)|Weight Decreased ( 177 Reports)|Vomiting ( 162 Reports)|Pruritus ( 157 Reports)|Fatigue ( 155 Reports)|Renal Failure Acute ( 149 Reports)|Asthenia ( 138 Reports)|Cough ( 137 Reports)|Constipation ( 129 Reports)|Blood Glucose Decreased ( 122 Reports)|Abdominal Pain ( 121 Reports)|Myalgia ( 120 Reports)|Malaise ( 118 Reports)|Abdominal Pain Upper ( 110 Reports)|Arthralgia ( 110 Reports)|Upper Respiratory Tract Infection ( 107 Reports)|Weight Increased ( 105 Reports)|Pancreatitis Acute ( 104 Reports)|Nasal Congestion ( 102 Reports)|Pain In Extremity ( 101 Reports)|